Tea-Drinking Habit among New University Students in Taiwan (article)

Hsiu Chen Tseng et al., “Tea-Drinking Habit among New University Students: Associated Factors,” Kaohsiung Journal of Medical Sciences 30, no. 2 (2014): 98–103. “Multiple logistic regression analysis showed the following factors were significant predictors of tea drinking: postgraduate students (p < 0.001), coffee drinking (p < 0.001), alcohol drinking (p < 0.001), minor mental morbidity (p = 0.009), poorer sleepers (p = 0.037), higher body mass index (p = 0.004), and sugar-sweetened beverage consumption (p < 0.001). Our data showed that the tea-drinking habit was correlated with higher body mass index, which was contrary to the findings of a previous study.”

Betel-nut beauties

Although betel nuts are Taiwan’s No. 2 crop after rice, the government feels that the health hazard it presents outweighs any economic benefits.

The Taiwanese government’s plan to curb cancer, though, faces tough opposition: about 60,000 women who sit in roadside glass booths, often wearing little more than a bikini, selling the nation’s oldest legal drug. The so-called betel-nut beauties, who are unique to Taiwan, peddle the nation’s second-largest crop to 17.5 percent of the adult male population, according to government estimates.

Chewing addictive betel nuts, the seed of the betel palm, increases the risk of mouth cancer, according to the Department of Health. Officials are encouraging farmers to plant alternatives to the US$359 million annual crop, urging about 1.6 million users to quit.

The Taipei Times reports.

Betel and Oral Cancer

For Science News, Diana Parsell reports on the link between oral cancer and betel chewing. She also notes that betel-chewing, while in decline in Thailand and Cambodia, is on the rise in Taiwan, India, Pakistan, and the United Kingdom. Here’s her report, “Palm-Nut Problem: Asian Chewing Habit Linked to Oral Cancer,” from page 43 of volume 167, number 3 (January 15, 2005).

This and more betel nut links can be found at Boing Boing, which has taken an interest in the drug.